{"id":11937,"date":"2008-01-15T11:30:00","date_gmt":"2008-01-15T10:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/pierrel-acquista-il-100-di-hyperphar-per-87-milioni\/"},"modified":"2008-01-15T11:30:00","modified_gmt":"2008-01-15T10:30:00","slug":"pierrel-acquista-il-100-di-hyperphar-per-87-milioni","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/pierrel-acquista-il-100-di-hyperphar-per-87-milioni\/","title":{"rendered":"PIERREL BUYS HYPERPHAR&#039;S 100% FOR 8.7 MILLION"},"content":{"rendered":"<p>&nbsp;<\/p>\n<p>Pierrel acquired the 100% of Hyperphar Group and its subsidiaries Farma Resa spa and Hyperphar Group Germany, as well as the 35% of the Dutch company Hyperphar Research Benelux Bv. The price was set at a maximum equity value of 8.7 million, paid for 6.3 million at the closing of the transaction and for 2.4 million through a deferred payment to be made on the basis of the 2007 result. In detail, Pierrel noted 55.55% from the shareholder and Luigi Visani (who took over Pierrel&#039;s 2% and will join the board of directors from February) and 35% from Wise Sgr, through the Wisequity fund.&nbsp; <\/p>","protected":false},"excerpt":{"rendered":"<p>&nbsp; Pierrel ha acquistato il 100% di Hyperphar Group e delle sue controllate Farma Resa spa e Hyperphar Group Germany, nonch&eacute; il 35% della societ&agrave; di diritto olandese Hyperphar Research Benelux Bv. Il prezzo stato fissato in un equity value massimo di 8,7 milioni, corrisposto per 6,3 milioni al closing dell&#8217;operazione e per 2,4 milioni &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-11937","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/11937","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=11937"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/11937\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=11937"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=11937"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=11937"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}